Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 531-538

  Corella, Dolores ^a   Carrasco, Paula ^a   Amiano, Pilar ^b   Arriola, Larraitz ^b   Chirlaque, María Dolores ^c   Huerta, José María ^c   Martínez, Carmen ^d   Martinez Camblor, Pablo ^b   Molina, Esther ^d   Navarro, Carmen ^c   Quirós, Juan R ^e   Rodríguez, Laudina ^e   Sánchez, María José ^d   Ortega Azorín, Carolina ^a   Ros, Emilio ^f   Sala, Nuria ^g   González, Carlos A ^g   Moreno, Concepción ^h  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^d ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^e Dirección General de Salud Pública y Planificación   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^h INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

Author keywords

Alcohol; Cardiovascular risk; CETP; Polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; HUMANS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 77955281670     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.026     Document Type: Article

References (41)

1. Rader D.J., Alexander E.T., Weibel G.L., Billheimer J., Rothblat G.H. Role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 2009, S189-S194.
2. Barkowski R.S., Frishman W.H. HDL metabolism and CETP inhibition. Cardiol Rev 2008, 16(3):154-162.
3. Ordovas J.M., Cupples L.A., Corella D., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000, 20:1323-1329.
4. Horne B.D., Carlquist J.F., Cannon-Albright L.A., et al. High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann Hum Genet 2006, 70:524-534.
5. Boekholdt S.M., Sacks F.M., Jukema J.W., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 2005, 111:278-287.
6. Thompson A., Di Angelantonio E., Sarwar N., et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008, 299:2777-2788.
7. Kathiresan S., Willer C.J., Peloso G.M., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 41:56-65.
8. Aulchenko Y.S., Ripatti S., Lindqvist I., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009, 41:47-55.
9. Eiriksdottir G., Bolla M.K., Thorsson B., Sigurdsson G., Humphries S.E., Gudnason V. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 2001, 159:187-192.
10. Freeman D.J., Samani N.J., Wilson V., et al. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study. Eur Heart J 2003, 24:1833-1842.
11. Park K.W., Choi J.H., Kim H.K., et al. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin Genet 2003, 63:31-38.
12. Liu S., Schmitz C., Stampfer M.J., et al. Prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 2002, 161:469-474.
13. Whiting B.M., Anderson J.L., Muhlestein J.B., et al. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease. Am Heart J 2005, 150:243-250.
14. McCaskie P.A., Beilby J.P., Chapman C.M., et al. Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease. Hum Genet 2007, 121:401-411.
15. Borggreve S.E., Hillege H.L., Wolffenbuttel B.H., et al. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab 2006, 91:3382-3388.
16. Hirano K., Yamashita S., Matsuzawa Y. Pros and cons of inhibiting cholesteryl ester transfer protein. Curr Opin Lipidol 2000, 11:589-596.
17. Neeli H., Rader D.J.A. Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?. Cardiol Clin 2008, 26:537-546.
18. de Haan W., de Vries-van der Weij J., van der Hoorn J.W., et al. Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin. Circulation 2008, 117:2515-2522.
19. Matsuura F., Wang N., Chen W., Jiang X.C., Tall A.R. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 2006, 116:1435-1442.
20. Vasan R.S., Pencina M.J., Robins S.J., et al. Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community. Circulation 2009, 120:2414-2420.
21. Fumeron F., Betoulle D., Luc G. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995, 96:1664-1671.
22. Corella D., Sáiz C., Guillén M., et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 2000, 152:367-376.
23. Talmud P.J., Hawe E., Robertson K., Miller G.J., Miller N.E., Humphries S.E. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann Hum Genet 2002, 66:111-124.
24. Jensen M.K., Mukamal K.J., Overvad K., Rimm E.B. Alcohol consumption. TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur Heart J 2008, 29:104-112.
25. González C.A., Navarro C., Martínez C., et al. The European prospective investigation on diet. Cancer, and health (EPIC) in Spain. Group EPIC of Spain. Med Clin (Barc) 1994, 102:781-785.
26. Riboli E., Hunt K.J., Slimani N., et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002, 5:1113-1124.
27. Danesh J., Saracci R., Berglund G., et al. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol 2007, 22:129-141.
28. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003, 108:2543-2549.
29. Wareham N.J., Jakes R.W., Rennie K.L., et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003, 6:407-413.
30. EPIC Group of Spain Relative validity and reproducibility of a diet history questionnaire in Spain. I. Foods. Int J Epidemiol 1997, 26(Suppl. 1):S91-S99.
31. Slimani N., Torrent M., Farriols N., et al. European prospective investigation into cancer and nutrition (EPIC): food composition tables-Spain 1991, International Agency for Research on Cancer, Lyon.
32. Pearson T.A. Alcohol and heart disease. Circulation 1996, 94:3023-3025.
33. Agudo A., Goñi F., Etxeandia A., et al. Polychlorinated biphenyls in Spanish adults: determinants of serum concentrations. Environ Res 2009, 109:620-628.
34. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
35. Padmaja N., Kumar R.M., Balachander J., Adithan C. Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population. Clin Chim Acta 2009, 402:139-145.
36. Dedoussis G.V., Panagiotakos D.B., Louizou E., et al. Cholesteryl ester-transfer protein (CETP) polymorphism and the association of acute coronary syndromes by obesity status in Greek subjects: the CARDIO2000-GENE study. Hum Hered 2007, 63:155-161.
37. Dullaart R.P., Sluiter W.J. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics 2008, 9:747-763.
38. van Acker B.A., Botma G.J., Zwinderman A.H. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants. Atherosclerosis 2008, 200:161-167.
39. Dullaart R.P., Beusekamp B.J., Riemens S.C. High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking, but not to moderate alcohol consumption in insulin-dependent diabetic men. Scand J Clin Lab Invest 1998, 58:251-258.
40. Kakko S., Tamminen M., Päivänsalo M., et al. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest 2001, 31:593-602.
41. Huerta J.M., Tormo M.J., Egea-Caparrós J.M., Ortolá-Devesa J.B., Navarro C. Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish population. DINO study findings. Rev Esp Cardiol 2009, 62:143-152.